Daybue Stix For Solution
Product Images NDC 63090-663

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Daybue Stix (NDC 63090-663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acadia Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Daybue 01)

Chemical Structure (Daybue 01)
Chemical structure of trofinetide, the active ingredient in Daybue Stix. The diagram shows molecular components and bonds characteristic of trofinetide's chemical composition.*
FDA Label Image

Figure 1 (Daybue 02)

Figure 1 (Daybue 02)
A line graph comparing change from baseline (LSM ± SE) over 12 weeks between Daybue and placebo groups. The x-axis shows study weeks (baseline, 2, 6, 12) and the y-axis shows change from baseline. Daybue shows a larger negative change compared to placebo, with sample sizes provided for each group at each time point below the x-axis.*
FDA Label Image

Figure 2 (Daybue 03)

Figure 2 (Daybue 03)
A bar chart comparing patient percentages by score on the CGI-I scale at week 12 for Daybue (trofinetide) oral solution versus placebo. The x-axis shows scores from 1 (very much improved) to 7 (very much worse), and the y-axis shows the percentage of patients. Daybue shows higher percentages in 'much improved' and 'minimally improved' categories compared to placebo, while placebo has a higher percentage in the 'no change' category.*
FDA Label Image

Principal Display Panel (450 mL Bottle Carton)

Principal Display Panel (450 mL Bottle Carton)
Packaging label for Daybue (trofinetide) oral solution 200 mg/mL in a 450 mL bottle. The label includes storage instructions, manufacturer information for Acadia Pharmaceuticals Inc., and usage notes for oral or G-tube administration. It features the Daybue logo with purple and teal design elements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.